OTCMKTS:ATTBF Abattis Bioceuticals (ATTBF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About Abattis Bioceuticals Stock (OTCMKTS:ATTBF) Get Abattis Bioceuticals alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume7,450 shsAverage Volume11,650 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Abattis Bioceuticals Corporation is a Canadian life sciences company focused on the development and commercialization of cannabis-derived and other botanical products. Its activities have included research, product formulation, extraction, manufacturing, and distribution within the cannabis and natural health-products sectors. The company has historically operated through subsidiaries and affiliated businesses involved in cannabis testing, nutraceutical development, natural health products, and cannabis-based formulations. Its portfolio has included products designed for wellness and therapeutic applications, although the availability and status of specific products and operations may have changed over time. Abattis has primarily served the Canadian market and has pursued opportunities connected with the regulated cannabis industry. Publicly available information about its current operations, product offerings, and leadership is limited, so a more detailed description cannot be provided reliably.AI Generated. May Contain Errors. Read More Receive ATTBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATTBF Stock News HeadlinesAbattis Bioceuticals Announces New CEOJune 27, 2026 | stockhouse.comAbattis Announces New Board MembersJune 27, 2026 | stockhouse.comThe Midwestern Disruptor Big Pharma Doesn’t Want You to Know AboutA little-known Midwestern firm sits at the center of what the Wall Street Journal calls medicine's biggest moment since antibiotics. It does not invent drugs or hold blockbuster patents. McKinsey calls the shift a game changer, and the International Journal of Surgery describes it as a revolutionary path forward. Yet this company remains largely overlooked by investors. See the full research on this emerging healthcare story now.October 14 at 1:00 AM | Compounding Quality (Ad)Abattis Provides Corporate UpdateJune 26, 2026 | finance.yahoo.comAbattis Bioceuticals Corp (ATTBF)October 2, 2024 | investing.comAbattis Bioceuticals Corp ATTBFNovember 11, 2023 | morningstar.comMAbattis Bioceuticals Corp ATTBF SustainabilitySeptember 9, 2022 | morningstar.comMWhen Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?March 27, 2022 | benzinga.comSee More Headlines ATTBF Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Abattis Bioceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Abattis Bioceuticals investors own include Canopy Growth (CGC), United Treatment Centers (POTN), Micron Technology (MU), Aurora Cannabis (ACB), Aurora Cannabis (ACB), Cronos Group (CRON) and GE Aerospace (GE). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ATTBF CIKN/A Webwww.abattis.com Phone808-650-3007FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:ATTBF) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredForget Biotech Stocks… This Is the Smarter PlayNVIDIA, Shopify, and TSMC built fortunes by powering innovation rather than betting on a single winner. One li...Compounding Quality | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abattis Bioceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abattis Bioceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.